J.Jill EVP, CFO & COO Mark Webb sells $122,600 in shares

Mark W. Webb, Executive Vice President, Chief Financial Officer, and Chief Operating Officer of J.Jill, Inc. (NASDAQ:JILL), sold 5,000 shares of the company’s common stock on October 19, 2026. The transactions totaled $122,600.

The shares were sold at prices ranging from $24.25 to $24.85 per share, with a weighted average price of $24.52. Following these transactions, Mr. Webb directly beneficially owns 113,523.43 shares of J.Jill common stock.The insider sale comes as JILL shares trade at $23.32, near their 52-week high of $25.14. According to InvestingPro Tips, the stock has delivered a high return over the last year, with shares up 52% over the past twelve months. The company currently appears undervalued based on InvestingPro’s Fair Value analysis. Investors can access 5 additional ProTips and comprehensive financial metrics through the platform’s detailed Pro Research Report, available for JILL and 1,400+ other US equities.

In other recent news, J.Jill reported fiscal second-quarter 2026 earnings that surpassed Wall Street expectations, with both profit and revenue exceeding forecasts. The company achieved an adjusted earnings per share of $1.24, significantly outperforming the anticipated $0.57, and reported revenue of $154.8 million, above the projected $151.26 million. Analysts have taken note of J.Jill’s performance, with Jefferies, BTIG, and TD Cowen all raising their price targets for the company to $25, citing the strong second-quarter results. Jefferies maintained a Buy rating, highlighting the company’s progress in product, marketing, and customer acquisition. BTIG also maintained a Buy rating, noting that J.Jill’s return to positive comparable sales marked a significant inflection point. TD Cowen, while maintaining a Hold rating, increased its price target to $25, acknowledging the encouraging signs of the company’s turnaround efforts. The firm’s previous price target adjustment to $22 was based on stronger execution and exceeded expectations for second-quarter comparable sales. These developments reflect growing confidence among analysts in J.Jill’s recovery trajectory.